{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:49:34Z","timestamp":1762505374595,"version":"3.35.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,7,22]],"date-time":"2008-07-22T00:00:00Z","timestamp":1216684800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmied Arch Pharmacol"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s00210-008-0329-0","type":"journal-article","created":{"date-parts":[[2008,7,21]],"date-time":"2008-07-21T05:06:18Z","timestamp":1216616778000},"page":"631-644","source":"Crossref","is-referenced-by-count":15,"title":["An in vitro model for assessment of drug-induced torsade de pointes arrhythmia"],"prefix":"10.1007","volume":"378","author":[{"given":"Stefan","family":"Dhein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska","family":"Perlitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedrich-Wilhelm","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,22]]},"reference":[{"key":"329_CR1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.0306-5251.2001.01511.x","volume":"53","author":"MJ Allen","year":"2002","unstructured":"Allen MJ, Oliver SD, Newgreen MW, Nichols DJ (2002) Pharmacodynamic effect of continuous versus intermittent dosing of dofetilide on QT interval. Br J Clin Pharmacol 53:59\u201365","journal-title":"Br J Clin Pharmacol"},{"key":"329_CR2","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1161\/01.RES.69.6.1427","volume":"69","author":"C Antzelevitch","year":"1991","unstructured":"Antzelevitch C, Sicouri S, Litovsky SH et al (1991) Heterogeneity within the ventricular wall: electrophysiology and pharmacology of epicardial, endocardial and M cells. Circ Res 69:1427\u20131449","journal-title":"Circ Res"},{"key":"329_CR3","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/01.RES.52.6.706","volume":"52","author":"G Arisi","year":"1983","unstructured":"Arisi G, Macchi E, Baruffi S, Spaggiari S, Taccardi B (1983) Potential field on the ventricular surface of the exposed dog heart during normal excitation. Circ Res 52:706\u2013715","journal-title":"Circ Res"},{"key":"329_CR4","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0735-1097(96)00588-8","volume":"29","author":"Y Asano","year":"1997","unstructured":"Asano Y, Davidenko JM, Baxter WT, Gray RA, Jalife J (1997) Optical mapping of drug-induced polymorphic arrhythmias and torsade de pointes in the isolated rabbit heart. J Am Coll Cardiol 29:831\u2013842","journal-title":"J Am Coll Cardiol"},{"key":"329_CR5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1600-0447.1989.tb10279.x","volume":"79","author":"NA Aunsholt","year":"1989","unstructured":"Aunsholt NA (1989) Prolonged Q-T interval and hypokalemia caused by haloperidol. Acta Psychiatr Scand 79:411\u2013412","journal-title":"Acta Psychiatr Scand"},{"key":"329_CR6","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0002-9149(99)80293-8","volume":"76","author":"Y Bashir","year":"1995","unstructured":"Bashir Y, Thomsen PE, Kingma JH, Moller M, Wong C, Cobbe SM, Jordaens L, Campbell RW, Rasmussen HS, Camm AJ (1995) Electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia. Dofetilide Arrhythmia Study Group. Am J Cardiol 76:1040\u20131044","journal-title":"Am J Cardiol"},{"key":"329_CR7","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.100.21.2184","volume":"100","author":"A Bauer","year":"1999","unstructured":"Bauer A, Becker R, Freigang KD, Senges JC, Voss F, Hansen A, M\u00fcller M, Lang HJ, Gerlach U, Busch A, Kraft P, K\u00fcbler W, Sch\u00f6ls W (1999) Rate- and site-dependent effects of propafenone, dofetilide, and the new I(Ks)-blocking agent chromanol 293b on individual muscle layers of the intact canine heart. Circulation 100:2184\u20132190","journal-title":"Circulation"},{"key":"329_CR8","first-page":"353","volume":"7","author":"HC Bazett","year":"1920","unstructured":"Bazett HC (1920) An analysis of the time relations of electrocardiograms. Heart 7:353\u2013370","journal-title":"Heart"},{"key":"329_CR9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-2999(99)00057-6","volume":"369","author":"AJ D\u2019Alonzo","year":"1999","unstructured":"D\u2019Alonzo AJ, Zhu JL, Darbenzio RB (1999) Effects of class III antiarrhythmic agents in an in vitro model of spontaneous torsade de pointes. Eur J Pharmacol 369:57\u201364","journal-title":"Eur J Pharmacol"},{"key":"329_CR10","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/01.CIR.79.3.674","volume":"79","author":"JM Davidenko","year":"1989","unstructured":"Davidenko JM, Cohen L, Goodrow R, Antzelevitch C (1989) Quinidine-induced action potential prolongation, early after-depolarizations and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium and magnesium. Circulation 79:674\u2013686","journal-title":"Circulation"},{"key":"329_CR11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1055\/s-2007-1024441","volume":"125","author":"S Dhein","year":"2000","unstructured":"Dhein S (2000) Arzneimittel induzierte QT-Verl\u00e4ngerung und Torsade de Pointes Arrhythmien. Dtsch Med Wochenschr 125:703\u2013708","journal-title":"Dtsch Med Wochenschr"},{"key":"329_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0020-7101(88)90014-1","volume":"23","author":"S Dhein","year":"1988","unstructured":"Dhein S, Rutten P, Klaus W (1988) A new method for analysing the geometry and timecourse of epicardial potential spreading. Int J Biomed Comput 23:201\u2013207","journal-title":"Int J Biomed Comput"},{"key":"329_CR13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0160-5402(89)90014-4","volume":"22","author":"S Dhein","year":"1989","unstructured":"Dhein S, M\u00fcller A, Klaus W (1989) The potential of epicardial activation mapping for the assessment of arrhythmogenic and antiarrhythmic drug activity. J Pharmacol Methods 22:197\u2013206","journal-title":"J Pharmacol Methods"},{"key":"329_CR14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF01907117","volume":"85","author":"S Dhein","year":"1990","unstructured":"Dhein S, M\u00fcller A, Klaus W (1990) Prearrhythmia: changes preceding arrhythmia, new aspects by epicardial mapping. Basic Res Cardiol 85:285\u2013296","journal-title":"Basic Res Cardiol"},{"key":"329_CR15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/01.CIR.87.2.617","volume":"87","author":"S Dhein","year":"1993","unstructured":"Dhein S, M\u00fcller A, Gerwin R, Klaus W (1993) Comparative study on the proarrhythmic effects of some class I antiarrhythmic agents. Circulation 87:617\u2013631","journal-title":"Circulation"},{"key":"329_CR16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00004714-199812000-00011","volume":"18","author":"MD Drici","year":"1998","unstructured":"Drici MD, Wang WX, Liu XK, Woosley RL, Flockhart DA (1998) Prolongation of QT interval in isolated feline hearts by antipsychotic drugs. J Clin Psychopharmacol 18:477\u2013481","journal-title":"J Clin Psychopharmacol"},{"key":"329_CR17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0002-8703(54)90249-5","volume":"47","author":"D Durrer","year":"1954","unstructured":"Durrer D, Van der Tweel LH (1954) Spread of activation in the left ventricular wall of the dog. Activation conditions at the epicardial surface. Am Heart J 47:192\u2013203","journal-title":"Am Heart J"},{"key":"329_CR18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00005344-199809000-00013","volume":"32","author":"L Eckardt","year":"1998","unstructured":"Eckardt L, Haverkamp W, Mertens H, Johna R, Clague JR, Borggrefe M, Breithardt G (1998) Drug-related torsade de pointes in the isolated rabbit heart: comparison of clofilium, d,l-sotalol and erythromycin. J Cardiovasc Pharmacol 32:425\u2013434","journal-title":"J Cardiovasc Pharmacol"},{"key":"329_CR19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/01.RES.79.3.474","volume":"79","author":"N El-Sherif","year":"1996","unstructured":"El-Sherif N, Caref EB, Yin H, Restivo M (1996) The electrophysiological mechanism of ventricular arrhythmias in the long QT syndrome. Tridimensional mapping of activation and recovery patterns. Circ Res 79:474\u2013492","journal-title":"Circ Res"},{"key":"329_CR20","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0735-1097(98)00700-1","volume":"33","author":"N El-Sherif","year":"1999","unstructured":"El-Sherif N, Caref EB, Chinushi M, Restivo M (1999) Mechanism of arrhythmogenicity of the short-long cardiac sequence that precedes ventricular tachyarrhythmias in the long QT syndrome. J Am Coll Cardiol 33:1415\u20131423","journal-title":"J Am Coll Cardiol"},{"key":"329_CR21","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0008-6363(02)00839-8","volume":"57","author":"L Fabritz","year":"2003","unstructured":"Fabritz L, Kirchhof P, Franz MR, Nuyens D, Rossenbacker T, Ottenhof A, Haverkamp W, Breithardt G, Carmeliet E, Carmeliet P (2003) Effect of pacing and mexiletine on dispersion of repolarisation and arrhythmias in DeltaKPQ SCN5A (long QT3) mice. Cardiovasc Res 57:1085\u20131093","journal-title":"Cardiovasc Res"},{"key":"329_CR22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00004714-198612000-00018","volume":"6","author":"SA Fayer","year":"1986","unstructured":"Fayer SA (1986) Torsades de pointes ventricular tachyarrhythmia associated with haloperidol (letter). J Clin Psychopharmacol 6:375\u2013376","journal-title":"J Clin Psychopharmacol"},{"key":"329_CR23","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1176\/appi.ajp.158.11.1774","volume":"158","author":"AH Glassman","year":"2001","unstructured":"Glassman AH, Bigger JT (2001) Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 158:1774\u20131782","journal-title":"Am J Psychiatry"},{"key":"329_CR24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/096032719101000110","volume":"10","author":"RA Henderson","year":"1991","unstructured":"Henderson RA, Lane S, Henry JA (1991) Life-threatening ventricular arrhythmia (torsades de pointes) after haloperidol overdose. Hum Exp Toxicol 10:59\u201362","journal-title":"Hum Exp Toxicol"},{"key":"329_CR25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1540-8167.2003.02466.x","volume":"14","author":"LM Hondeghem","year":"2003","unstructured":"Hondeghem LM, Lu HR, van Rossem K, De Clerck F (2003) Detection of proarrhythmia in the female rabbit heart: blinded validation. J Cardiovasc Electrophysiol 14:287\u2013294","journal-title":"J Cardiovasc Electrophysiol"},{"key":"329_CR26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0033-3182(95)71609-7","volume":"36","author":"N Hunt","year":"1995","unstructured":"Hunt N, Stern TA (1995) The association between intravenous haloperidol and torsades de pointes: three cases and a literature review. Psychosomatics 36:541\u2013549","journal-title":"Psychosomatics"},{"key":"329_CR27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1600-0447.2004.00469.x","volume":"111","author":"D Justo","year":"2005","unstructured":"Justo D, Prokhorov V, Heller K, Zeltser D (2005) Torsade de pointes induced by psychotropic drugs and the prevalence of its risk factors. Acta Psychiatr Scand 111:171\u2013176","journal-title":"Acta Psychiatr Scand"},{"key":"329_CR28","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1124\/jpet.105.093393","volume":"316","author":"AN Katchman","year":"2006","unstructured":"Katchman AN, Koerner J, Tosaka T. Woosley RL, Ebert SN (2006) Comparative evaluation of HERG currents and QT intervals following challenge with suspected torsadogenic and nontorsadogenic drugs. J Pharmacol Exp Ther 31.6:1098\u20131106","journal-title":"J Pharmacol Exp Ther"},{"key":"329_CR29","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1378\/chest.98.2.482","volume":"98","author":"M Kriwisky","year":"1990","unstructured":"Kriwisky M, Perry GY, Tarchitsky D, Gutman Y, Kishon Y (1990) Haloperidol-induced torsades de pointes. Chest 98:482\u2013484","journal-title":"Chest"},{"key":"329_CR30","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0008-6363(98)00269-7","volume":"41","author":"D Lacroix","year":"1999","unstructured":"Lacroix D, Extramiana F, Delfaut P, Adamantidis M, Grandmougin D, Klug D, Kacet S, Dupuis B (1999) Factors affecting epicardial dispersion of repolarization: a mapping study in the isolated porcine heart. Cardiovasc Res 41:563\u2013574","journal-title":"Cardiovasc Res"},{"key":"329_CR31","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0735-1097(96)00589-X","volume":"29","author":"R Lazzara","year":"1997","unstructured":"Lazzara R (1997) Twisting the points. J Am Coll Cardiol 29:843\u2013845","journal-title":"J Am Coll Cardiol"},{"key":"329_CR32","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1161\/01.CIR.94.10.2535","volume":"94","author":"MH Lehmann","year":"1996","unstructured":"Lehmann MH, Hardy S, Archibald D, Quart B, McNeil DJ (1996) Sex difference in risk of torsade de pointes with d,l-sotalol. Circulation 94:2535\u20132541","journal-title":"Circulation"},{"key":"329_CR33","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1358\/dot.2000.36.11.601530","volume":"36","author":"TL Lenz","year":"2000","unstructured":"Lenz TL, Hilleman DE (2000) Dofetilide: a new antiarrhythmic agent approved for conversion and\/or maintenance of atrial fibrillation\/atrial flutter. Drugs Today (Barc) 36:759\u2013771","journal-title":"Drugs Today (Barc)"},{"key":"329_CR34","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1540-8167.2005.40677.x","volume":"16","author":"J Liu","year":"2005","unstructured":"Liu J, Laurita KR (2005) The mechanism of pause-induced torsade de pointes in long QT syndrome. J Cardiovasc Electrophysiol 16:981\u2013987","journal-title":"J Cardiovasc Electrophysiol"},{"key":"329_CR35","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1001\/jama.1993.03510210076031","volume":"270","author":"RR Makkar","year":"1993","unstructured":"Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH (1993) Female gender as a risk factor for torsade de pointes associated with cardiovascular drugs. JAMA 270:2590\u20132597","journal-title":"JAMA"},{"key":"329_CR36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005344-200403000-00007","volume":"43","author":"RL Martin","year":"2004","unstructured":"Martin RL, McDermott JS, Salmen HJ, Palmatier J, Cox BF, Gintant GA (2004) The utility of hERG and repolarization assays in evaluating delayed cardiac repolarization: influence of multi-channel block. J Cardiovasc Pharmacol 43:369\u2013379","journal-title":"J Cardiovasc Pharmacol"},{"key":"329_CR37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00004714-199304000-00007","volume":"13","author":"E Metzger","year":"1993","unstructured":"Metzger E, Friedman R (1993) Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill. J Clin Psychopharmacol 13:128\u2013132","journal-title":"J Clin Psychopharmacol"},{"key":"329_CR38","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/01.CIR.72.6.1372","volume":"72","author":"CK Millar","year":"1985","unstructured":"Millar CK, Kralios FA, Lux RL (1985) Correlation between refractory periods and activation recovery intervals from electrograms: effects of rate and adrenergic interventions. Circulation 72:1372\u20131379","journal-title":"Circulation"},{"key":"329_CR39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1540-8167.1991.tb01313.x","volume":"2","author":"A M\u00fcller","year":"1991","unstructured":"M\u00fcller A, Dhein S, Klaus W (1991) Heteregeneously distributed sensitivities to potassium as a cause of hypokalemic arrhythmias in isolated rabbit hearts. J Cardiovasc Electrophysiol 2:145\u2013155","journal-title":"J Cardiovasc Electrophysiol"},{"key":"329_CR40","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/nm0901-1021","volume":"7","author":"D Nuyens","year":"2001","unstructured":"Nuyens D, Stengl M, Dugarmaa S, Rossenbacker T, Compernolle V, Rudy Y, Smits JF, Flameng W, Clancy CE, Moons L, Vos MA, Dewerchin M, Benndorf K, Collen D, Carmeliet E, Carmeliet P (2001) Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat Med 7:1021\u20131027","journal-title":"Nat Med"},{"key":"329_CR41","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.amjcard.2007.04.020","volume":"100","author":"HS Pedersen","year":"2007","unstructured":"Pedersen HS, Elming H, Seibaek M, Burchardt H, Brendorp B, Torp-Pedersen C, Kober L, DIAMOND Study Group (2007) Risk factors and predictors of Torsade de Pointes ventricular Tachycardia in patients with left ventricular systolic dysfunction receiving dofetilide. Am J Cardiol 100:876\u2013880","journal-title":"Am J Cardiol"},{"key":"329_CR42","first-page":"675","volume":"4","author":"CL Raehl","year":"1985","unstructured":"Raehl CL, Patel AK, LeRoy M (1985) Drug-induced torsade de pointes. Clin Pharm 4:675\u2013690","journal-title":"Clin Pharm"},{"key":"329_CR43","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00395-004-0469-4","volume":"99","author":"KD Schreiner","year":"2004","unstructured":"Schreiner KD, Voss F, Senges JC, Becker R, Kraft P, Bauer A, Kelemen K, Kuebler W, Vos MA, Schoels W (2004) Tridimensional activation patterns of acquired torsade-de-pointes-tachycardias in dogs with chronic AV-block. Basic Res Cardiol 99:288\u2013298","journal-title":"Basic Res Cardiol"},{"key":"329_CR44","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0002-9149(97)00888-6","volume":"81","author":"ND Sharma","year":"1998","unstructured":"Sharma ND, Rosman HS, Padhi ID, Tisdale JE (1998) Torsades de pointes associated with intravenous haloperidol in critically ill patients. Am J Cardiol 81:238\u2013240","journal-title":"Am J Cardiol"},{"key":"329_CR45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1540-8167.1993.tb01211.x","volume":"4","author":"S Sicouri","year":"1993","unstructured":"Sicouri S, Antzelevitch C (1993) Drug-induced afterdepolarizations and triggered activity occur in a discrete subpopulation of ventricular muscle cells (M cells) in the canine heart: quinidine and digitalis. J Cardiovasc Electrophysiol 4:48\u201358","journal-title":"J Cardiovasc Electrophysiol"},{"key":"329_CR46","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0026-895X(25)09019-4","volume":"49","author":"DJ Snyders","year":"1996","unstructured":"Snyders DJ, Chaudhary A (1996) High affinity open channel block by dofetilide of HERG expressed in a human cell line. Mol Pharmacol 49:949\u2013955","journal-title":"Mol Pharmacol"},{"key":"329_CR47","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/cvr\/cvm060","volume":"77","author":"M Stoll","year":"2008","unstructured":"Stoll M, Quentin M, Molojavyi A, Th\u00e4mer V, Decking UK (2008) Spatial heterogeneity of myocardial perfusion predicts local potassium channel expression and action potential duration. Cardiovasc Res 77:489\u2013496","journal-title":"Cardiovasc Res"},{"key":"329_CR48","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/sj.bjp.0700989","volume":"120","author":"H Suessbrich","year":"1997","unstructured":"Suessbrich H, Schonherr R, Heinemann SH et al (1997) The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes. Br J Pharmacol 120:968\u2013974","journal-title":"Br J Pharmacol"},{"key":"329_CR49","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0735-1097(89)90069-7","volume":"14","author":"B Surawicz","year":"1989","unstructured":"Surawicz B (1989) Electrophysiologic substrate of torsade de pointes: dispersion of repolarization or early afterdepolarizations. J Am Coll Cardiol 14:172\u2013184","journal-title":"J Am Coll Cardiol"},{"key":"329_CR50","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1177\/00912700122012896","volume":"41","author":"JE Tisdale","year":"2001","unstructured":"Tisdale JE, Rasty S, Padhi ID, Sharma ND, Rosman H (2001) The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of torsade de pointes. J Clin Pharmacol 41:1310\u20131318","journal-title":"J Clin Pharmacol"},{"key":"329_CR51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/00002018-200528010-00003","volume":"28","author":"K Titier","year":"2005","unstructured":"Titier K, Girodet PO, Verdoux H, Molimard M, Begaud B, Haverkamp W, Lader M, Moore N (2005) Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death. Drug Saf 28:35\u201351","journal-title":"Drug Saf"},{"key":"329_CR52","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0008-6363(97)00067-9","volume":"34","author":"SC Verduyn","year":"1997","unstructured":"Verduyn SC, Vos MA, van der Zande J, van der Hulst FF, Wellens HJ (1997) Role of interventricular dispersion of repolarization in acquired torsade de pointes arrhythmias: reversal by magnesium. Cardiovasc Res 34:453\u2013463","journal-title":"Cardiovasc Res"},{"key":"329_CR53","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s004240100720","volume":"443","author":"M Weerapura","year":"2002","unstructured":"Weerapura M, Hebert TE, Nattel S (2002) Dofetilide block involves interations with open and inactivated states of HERG channels. Pfl\u00fcgers Arch 443:520\u2013531","journal-title":"Pfl\u00fcgers Arch"},{"key":"329_CR54","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1540-8167.1997.tb01014.x","volume":"8","author":"M Zabel","year":"1997","unstructured":"Zabel M, Hohnloser SH, Behrens S, Woosley RL, Franz MR (1997) Differential effects of D-sotalol, quinidine, and amiodarone on dispersion of ventricular repolarization in the isolated rabbit heart. J Cardiovasc Electrophysiol 8:1239\u20131245","journal-title":"J Cardiovasc Electrophysiol"},{"key":"329_CR55","first-page":"325","volume":"256","author":"G Zuanetti","year":"1991","unstructured":"Zuanetti G, Corr PB (1991) Antiarrhythmic efficacy of a new class III agent, UK-68,798, during chronic myocardial infarction: evaluation using three-dimensional mapping. J Pharmacol Exp Ther 256:325\u2013334","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-008-0329-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-008-0329-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-008-0329-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T03:10:15Z","timestamp":1738293015000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-008-0329-0"}},"subtitle":["Effects of haloperidol and dofetilide on potential duration, repolarization inhomogeneities, and torsade de pointes arrhythmia"],"short-title":[],"issued":{"date-parts":[[2008,7,22]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["329"],"URL":"https:\/\/doi.org\/10.1007\/s00210-008-0329-0","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"type":"print","value":"0028-1298"},{"type":"electronic","value":"1432-1912"}],"subject":[],"published":{"date-parts":[[2008,7,22]]}}}